MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Assertio Holdings Inc

Slēgts

0.66 -1.49

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.65

Max

0.67

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.1M

-14M

Pārdošana

-5.7M

26M

Peļņas marža

-51.121

Darbinieki

58

EBITDA

-10M

-13M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+317.91% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

6.7M

66M

Iepriekšējā atvēršanas cena

2.15

Iepriekšējā slēgšanas cena

0.66

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Assertio Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 18. jūl. 21:01 UTC

Peļņas

Charles Schwab Profit Jumps on Tariff Trading Surge -- 2nd Update

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Basic Materials Roundup: Market Talk

2025. g. 18. jūl. 20:46 UTC

Peļņas

Strong Earnings Fuel Stock-Market Records This Week -- WSJ

2025. g. 18. jūl. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific Considering a Norfolk Southern Buyout, Report Says. Here's What Will Matter. -- Barrons.com

2025. g. 18. jūl. 20:36 UTC

Peļņas

3M Gives Investors a 'Beat and Raise.' The Stock Is Rising. -- Barrons.com

2025. g. 18. jūl. 20:16 UTC

Iegādes, apvienošanās, pārņemšana

Chevron-Hess Deal Close Is Good News for Wall Street's Takeover Arbitragers -- Barrons.com

2025. g. 18. jūl. 20:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 18. jūl. 20:02 UTC

Tirgus saruna

Gold Higher to Close Out Week -- Market Talk

2025. g. 18. jūl. 19:14 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

2025. g. 18. jūl. 19:06 UTC

Tirgus saruna

Oil Futures Snap Two-Week Winning Streak -- Market Talk

2025. g. 18. jūl. 18:24 UTC

Peļņas

These Stocks Are Moving the Most Today: Netflix, Sarepta, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, and More -- Barrons.com

2025. g. 18. jūl. 18:19 UTC

Peļņas

American Express Shares Drop as Earnings Beat, Record Revenue Fail to Impress -- Barrons.com

2025. g. 18. jūl. 18:11 UTC

Iegādes, apvienošanās, pārņemšana

Oil CEOs Get Their Revenge on Biden's Antitrust Enforcers -- WSJ

2025. g. 18. jūl. 18:11 UTC

Peļņas

Netflix Earnings Show That YouTube Is the Streamer to Fear -- Barrons.com

2025. g. 18. jūl. 17:35 UTC

Tirgus saruna

U.S. Oil Rig Count Falls by 2 to 422 -- Market Talk

2025. g. 18. jūl. 16:29 UTC

Tirgus saruna

Crude Rally on EU's Russia Sanctions Peters Out -- Market Talk

2025. g. 18. jūl. 16:28 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific Considering a Norfolk Southern Buyout, Report Says. Here's What Will Matter. -- Barrons.com

2025. g. 18. jūl. 16:22 UTC

Peļņas

These Stocks Are Moving the Most Today: Netflix, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, Sarepta, and More -- Barrons.com

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Energy & Utilities Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Basic Materials Roundup: Market Talk

2025. g. 18. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 18. jūl. 16:04 UTC

Peļņas

Charles Schwab Profit Jumps on Tariff Trading Surge -- Update

2025. g. 18. jūl. 15:58 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 18. jūl. 15:58 UTC

Tirgus saruna

Aluminum Gains on U.S. Dollar Weakness, Scrap Imports -- Market Talk

2025. g. 18. jūl. 15:47 UTC

Tirgus saruna
Peļņas

Netflix Shifting Focus to Engagement with New Content -- Market Talk

Salīdzinājums

Cenas izmaiņa

Assertio Holdings Inc Prognoze

Cenas mērķis

By TipRanks

317.91% augšup

Prognoze 12 mēnešiem

Vidējais 2.8 USD  317.91%

Augstākais 3.5 USD

Zemākais 1.5 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Assertio Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

5 ratings

4

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.618 / 0.649Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.